What do we know about the renin angiotensin system and inflammatory bowel disease?

Lo, Sheng Wei; Segal, Jonathan P; Lubel, John S; Garg, Mayur

Lo, Sheng Wei; Segal, Jonathan P; Lubel, John S; Garg, Mayur.

Affiliation

Lo SW; Department of Gastroenterology, Northern Hospital, 3076 Melbourne, Australia.
Segal JP; Department of Gastroenterology, Northern Hospital, 3076 Melbourne, Australia.
Lubel JS; Department of Medicine, University of Melbourne, Australia.
Garg M; Department of Gastroenterology, Northern Hospital, 3076 Melbourne, Australia.

Expert Opin Ther Targets ; 26(10): 897-909, 2022 10.

Article in En | MEDLINE | ID: mdl-36484415

Subject(s)

COVID-19; Inflammatory Bowel Diseases; Humans; Renin-Angiotensin System; SARS-CoV-2; Inflammatory Bowel Diseases/drug therapy; Fibrosis

Key words

Angiotensin converting enzyme 2; angiotensin converting enzyme inhibitor; angiotensin receptor blocker; gastrointestinal tract; inflammatory bowel disease; renin angiotensin system

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Limits: Humans Language: En Journal: Expert Opin Ther Targets Journal subject: TERAPEUTICA Year: 2022 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google